TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Beactica Therapeutics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
7,385
|
7,341
|
4,469 |
Financial expenses |
110
|
109
|
142 |
Earnings before taxes |
-9,019
|
-10,651
|
-10,199 |
EBITDA |
-8,742
|
-10,340
|
-9,520 |
Total assets |
29,972
|
36,506
|
28,343 |
Current assets |
4,276
|
12,875
|
6,622 |
Current liabilities |
2,368
|
4,322
|
4,846 |
Equity capital |
27,118
|
31,135
|
21,699 |
- share capital |
358
|
337
|
297 |
Employees (average) |
9
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.5%
|
85.3%
|
76.6% |
Turnover per employee |
821
|
918
|
559 |
Profit as a percentage of turnover |
-122.1%
|
-145.1%
|
-228.2% |
Return on assets (ROA) |
-29.7%
|
-28.9%
|
-35.5% |
Current ratio |
180.6%
|
297.9%
|
136.6% |
Return on equity (ROE) |
-33.3%
|
-34.2%
|
-47.0% |
Change turnover |
44
|
2,872
|
1,528 |
Change turnover % |
1%
|
64%
|
52% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
13%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.